Our weight loss program in San Francisco, California does prescribe weight loss medications to patients who we feel can benefit from them
Navigating The GLP-1 Litigation Landscape By James Gourley, Partner, Carstens, Allen & Gourley The GLP-1 drug market is booming, fueled by their success in treating diabetes and obesity
This guide is here to help you understand what many people experience, how to eat in a supportive way, and how to stay steady while your body finds its rhythm
Luckily, one expert from Baylor College of Medicine has tips on how to enjoy holiday fare while on these medications, without overdoing it
Although GFAP remains widely used as a clinical marker of astrogliosis, it lacks the specificity required to distinguish maladaptive from adaptive astrocytic states, thereby limiting its diagnostic and prognostic utility
Here are a few questions to help guide your discussions: Is your organization prepared to address obesity as a workforce health priority beyond just GLP-1 access